shows approximately 1% of lifetime prevalence. 1 The outcome of schizophrenia is known to be diverse and heterogenic. Among the patients receiving standard treatment, approximately 20-40% experienced recurrence within a year, 60% ObjectiveaaNon-adherence to medication is a recognized problem in psychiatric patients and may be one of the most challenging aspects of treatment for patients with schizophrenia. Failure of follow-up care after discharge greatly increases non-adherence to prescribed medications, relapse and rehospitalization. However, it is still unknown whether and how much outpatient follow-up visits can mitigate the risk of rehospitalization. Therefore we sought to investigate the continuity and effectiveness of outpatient care after inpatient discharge and its effect on rehospitalization of patients with schizophrenia. MethodsaaData were extracted from National Health Insurance Claim Database covering the period from 2007 through 2010. We identified 10,246 patients aged 18 years or older who were admitted in psychiatric facilities with the diagnosis of schizophrenia between January 1 and December 31 in 2007. The number of outpatient visits within 60 days after discharge from index admission was defined as the indicator for the continuous care and rehospitalization was inspected during the following 36-month period. Cox's proportional hazard model was used to examine the factors affecting the risk of rehospitalization including the number of outpatient visits, age, sex, comorbidities, antipsychotics, and characteristics of medical institution. ResultsaaWe found that 12.7% (n=1,327) of the patients visited psychiatric outpatient department once within 60 days after hospital discharge, 34.8% (n=3,626) twice, and 27.8% (n=2,900) more than three times. Patients taking atypical antipsychotics showed higher proportion in 2 or more outpatient visits, whereas patients taking typical antipsychotics showed higher proportion in one or no outpatient visits. Cox hazard ratios of rehospitalization for the factor of 3 or more outpatient visits referenced to that of no follow-up visit were 0.567 (0.428-0.750, 95% confidence interval) within 90 days, 0.673 (0.574-0.789) within 180 days, 0.800 (0.713-0.898) within a year, 0.906 (0.824-0.997) within 2 years, and 0.993 (0.910-1.084) within 3 years. ConclusionaaAlthough continuous outpatient treatment is important for relapse prevention, patients with schizophrenia showed a low rate of outpatient visit as 62.6% of total patients in 2 or more visits within 60 days after discharge. Lack of follow-up treatment might lead to increase psychotic symptoms and raised risk of relapse and rehospitalization. Our data suggest that the number of outpatient visits within 60 days after discharge in patients with schizophrenia is an important indicator of rehospitalization within a year. Therefore, further efforts to examine factors affecting failure of outpatient follow-up after discharge are warranted.
INTRODUCTION
within two years and 82% within 5 years. [2] [3] [4] [5] [6] [7] Medical care cost of such relapsed patients is about twice as much as that of the patients without recurrence, 61% of which is related to hospitalization. 1, 8 Therefore, it is very important to identify the factors affecting recurrence and rehospitalization.
Variables related to recurrence or rehospitalization have been studied, including male sex, old age, single or divorced marital status, early occurrence, history of multiple hospitalizations, severe symptoms during hospitalization and after discharge, unemployment, level of adaptation before occurrence, accompaniment of material abuse, and reduced compliance after discharge. 7, [9] [10] [11] [12] [13] [14] [15] In particular, low drug compliance is the most common factor contributing to recurrence and rehospitalization of patients with schizophrenia, and is strongly related to negative outcomes such as aggravated symptoms, social withdrawal. [15] [16] [17] High discontinuation rate of antipsychotics in patients with schizophrenia has been documented in previous studies. In the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE), 74% of chronic schizophrenia patients discontinued their medication within 18 months, 18 and in the European First Episode Schizophrenia Trial (EUFEST), 42% incipient schizophrenia patients discontinued within 12 months. 19 Apparently, the discontinuing medication increases the risk of recurrence by 5 times. 7 Thus, to prevent recurrence and rehospitalization and improve their social adaptation, improving adherence of antipsychotic medication is essential, and a regular and constant outpatient care may foster such adherence. 20 Although the critical importance of regular outpatient treatment is being recognized, naturalistic studies found that 33-44% patients quit treatment within the first 6 months and 59% within the first year. [21] [22] [23] [24] [25] [26] [27] Medication non-adherence was more common among patients with than without recurrence (70% vs. 25%, p=0.001). Thus, discontinuing medication due to drop out from outpatient care is a major risk factor of rehospitalization of patients with schizophrenia. [28] [29] [30] However, there is a paucity of research on the association between outpatient care and rehospitalization. Former studies focused on patient's characteristics or index hospitalizationrelated factors. 11, [31] [32] [33] [34] Only a handful of studies have shown that regular outpatient visit after discharge was related to a low rate of rehospitalization and high drug compliance. 29, 35, 36 As was shown in the report by Tiihonen et al., the group taking antipsychotics showed a significantly lower rehospitalization rate, though 1,496 out of 2,588 patients (57.8%) were rehospitalized during the two-year follow-up observation period. 37 Thus, to reduce rehospitalization rate, maintenance of regular medication through outpatient care is of critical importance.
Early rehospitalization within 30 days after discharge may be associated with short hospitalization in the last treatment, symptoms at the time of recurrence, effects of treatment during hospitalization, and discharge plan of inpatient. However, it fails to reflect the intervention effects of outpatient treatment after discharge. 10, 34, 36, 38 Accordingly, this study focused on outpatient visits after discharge and we extended the observation period to 60 days to identify the relationship between outpatient visits and rehospitalization.
In this study, we hypothesized that the number of outpatient visits within 60 days after discharge was inversely related to the risk of rehospitalization. Therefore, we compared various factors among subgroups based on the number of outpatient visits within 60 days after discharge and sought to elucidate the effects of outpatient visits on the rehospitalization rate within three years using National Health Insurance Claim Database (NHICD).
METHODS

Data source
We performed a population-based retrospective cohort study, using data extracted from NHICD. Korea has a national health insurance system and the medical cost claimed by medical institutions is reviewed by Health Insurance Review & Assessment Service. NHICD encompasses a wide range of clinical information including general characteristics of patients, diagnosis, medical treatment history and medical institution characteristics.
This study was performed as a part of the development OECD Healthcare quality indicators in 2009 supported by Ministry of Health and Welfare in Korea.
Study population
The subjects were patients with schizophrenia aged over 18 years and admitted between January 1 and December 31 in the year of 2007. For the definition of patients with schizophrenia, we included patients whose principal or first secondary diagnosis was either schizophrenia (F20.0-F20.9) or schizoaffective disorders (F25.0, F25.1, F25.2, F25.8, F25.9) based on the 10th revision of International Statistical Classification of Diseases and Related Health Problems (ICD-10). 39 Patients who were subject to medical aid were excluded because details on prescriptions were not available in NHICD. Among 19,570 patients who met our primary selection criteria, those who were rehospitalized, transferred to other hospital, or expired within 60 days after discharge were excluded because they have not been benefited from outpatient treatment. Finally, 10,426 patients taking antipsychotics during or after the hospitalization were included 3-year follow-up observation.
Variables
Outpatient visit and rehopitalization
In this study, the correlation between outpatient visits after discharge and recurrence was analyzed. Based on the number of outpatient visits within 60 days after discharge, patients were categorized into four groups: never, once, twice, and three times or more. We defined rehospitalization as the event for survival analysis and regarded it as a result from recurrence of schizophrenia. Rehospitalization was checked for three years starting from post-discharge 61st day.
Other explanatory variables
The medical institutions of the index hospitalization were classified into general hospital, hospital and private clinic according to the types of facility, and into metropolitan city, small urban and rural district according to the location. Comorbidities such as hypertension and diabetes and past hospitalization history, length of stay (LOS) at the index admission and use of typical or atypical antipsychotics were selected as covariates. Use of atypical antipsychotics was defined as any use of it for any length of time during the observation period. We also examined comorbidities including depression (F32. x, F33.x, F341, and F412), anxiety disorder(F40.x-F43.x), hypertension(I10.x-I15.x), and diabetes (E10.x-E14.x). Past hospitalization history was defined as any psychiatric within a year before the index hospitalization in 2007.
Statistical analysis
ANOVA with tukey's multiple comparison for continuous variables and Cochrane-Amitage's linear trend test or ChiSquare test for categorical variables in the analysis of groups based on the number of outpatient visits. Using Kaplan-Meier method, we carried out rehospitalization-free survival analysis and compared the survival curves of the four groups. To analyze the risk factors for rehospitalization, we used timedependent Cox's proportional hazard model with covariates, including age, gender, LOS, comorbidities, drug prescription and medical institution characteristics. SAS 9.13 (SAS Institute, Cary, NC, USA) was used for statistical analysis, and the significance level for all the tests was 0.05.
RESULTS
General characteristics of discharged schizophrenia patients
We included total 10,426 patients, among which 53.1% were female (n=5,531) and 47.0% male (n=4,895). The mean age of patients was 39.5 years. Past hospitalization was present in 27%, and use of atypical antipsychotics at the time of discharge was found in 90.4% of the patients, showing a high atypical antipsychotics prescription rate. The prevalences of hypertension and diabetes were 6.8% and 5.5%, respectively. Those of depression and anxiety disorder were 14.7%, and 11.3%, respectively. Majority of patients (87.9%) were hospitalized in general hospital or hospital, and a half of the patients (49%) visited medical institutions located in large cities (Table 1) .
General characteristics according to the number of outpatient visits after discharge
A quarter of patients (n=2,573; 24.7%) never had outpatient visit within 60 days after discharge. Those who had one outpatient visit were 12.7% (n=1,327), two visits 34.8% (n=3,626), more than three visits 27.8% (n=2,900). Among the patients over 65 years of age, those who never had outpatient visit after discharge were 61.5%, while those with more than three visits 8.3%. On the other hand, among patients between 18 and 44 years of age, 30.4% had more than three outpatient visits. Female patients showed a slightly higher number of visits than male although the difference was statistically insignificant.
Patients with a longer period of hospitalization showed more outpatient visits and those with an experience of prior hospitalization showed a higher rate of outpatient visits. Patients who had depression or anxiety disorder had more outpatient visits, but there was no difference in the number of outpatient visits between patients with and without hypertension or diabetes.
Although one outpatient visit rate of patients who had typical antipsychotics was higher (13.4%) than those who had atypical antipsychotics (12.7%), patients who had atypical antipsychotics showed a higher outpatient visit rate after discharge. Proportions of patients with 2 and 3 or more outpatient visits were higher in patients taking atypical antipsychotics (27.3% and 25.4%, respectively), whereas those of one or no outpatient visits was higher in patients taking typical antipsychotics (12.7% and 23.7, respectively).
According to medical institution type, patients hospitalized in general hospitals or hospitals showed higher proportion in one and two outpatient visits than those hospitalized in private clinic but the proportion in three or more visits were highest in private clinic (49.6%). When medical institutions were located in rural district, the patients showed a lower outpatient visit rate compared to those of the institutions in city area (metropolitan city or small urban).
Multivariate analysis between the number of outpatient visits and rehospitalization
We analyzed the association between the number of outpatient visits within 60 days after discharge and rehospitalization within 90 days, 180 days, 1 year, 2 years and 3 years after discharge. The risk of rehospitalization of patients who had 3 or more outpatient visits relative to that of counterpart without outpatient visit within 90 days was 0.567 (0.428-0.750, 95% confidence interval), within 180 days was 0.673 (0.574-0.789), within a year was 0.800 (0.713-0.898), within 2 years 0.906 (0.824-0.997), which had a trend level significance and within 3 years 0.993 (0.910-1.084) ( Table 2) . Kaplan-Meier analysis of rehospitalization-free survival in subgroups according to the number of outpatient visits showed that the difference in rehospitalization-free survival between subgroups was reduced after a year (Figure 1) .
Length of inpatient stay, which was selected as proxy variable of severity of patients, did not have a significant association with risk of rehospitalization, and the risk of rehospitalization became lower with age. Patients with comorbidities such as hypertension, diabetes, depression and anxiety disorder showed a higher risk of rehospitalization and those taking atypical antipsychotics had a lower risk of rehospitalization. Additionally, patients hospitalized in hospital or private clinic showed a higher rehospitalization risk than those hospitalized in general hospital. There was no significant difference in the risk of rehospitalization among the types of the area where the psychiatric institution is located in.
DISCUSSION
This study analyzed the association between outpatient visit and rehospitalization in patients with schizophrenia hospitalized in 2007. We could identify the association between outpatient visits and rehospitalization by performing a threeyear follow-up observation. It was confirmed that more outpatient visits within 60 days after discharge could lower the risk of rehospitalization within one year. Thus, the number of outpatient visits after discharge turned out to be a very important indicator of rehospitalization in maintenance treatment of schizophrenia. Some previous studies have emphasized the importance of outpatient visits after discharge. Lin et al. showed that Taiwanese patients with at least one outpatient visit within 60 days after discharge have a reduced risk of rehospitalization. 38 Nelson et al. reported that patients with no outpatient visit after discharge have twice the risk of rehospitalization within a year, 36 and Grinshpoon et al. 40 reported that psychiatric patients with outpatient visits showed a significantly lower rehospitalization rate within 6 months than those without outpatient visits. Interestingly, we also found that the effects of outpatient visits were lost after a year. It is plausible that the predictability might have been weakened over time, because a relatively short period was investigated as an index period for post-discharge outpatient visits. Also, various factors such as use of community service, life events, or wax-and-wane nature of schizophrenia per se, might confound the association between the outpatient visits and rehospitalization in a longer period. To decide the index period of post-discharge visit for our study, it was inevitable to trade off representing ability against confounding effects. If the index period is too short it may not represent the tendency of outpatient visits, but if it is too long, the odds of being confounded by other factors might grow higher. The index period to "2 months after discharge" has been used in prior study as well. 38 These results suggest that not only inpatient treatment but also outpatient treatment is important. It has been shown that the compliance of outpatient appointment is higher when both the inpatient and outpatient care was provided by the same physician. 41 Additionally, the first outpatient visit rate of the patients increases when there is a consultation between the inpatient doctor and outpatient doctor regarding the discharge plan during the hospitalization. 42 Consequently, in order to minimize recurrence and rehospitalization, the establishment of post-discharge outpatient appointments seems to be critical.
The number of patients who failed to have outpatient visits within 60 days after discharge were 2,573 (24.7%). The overall number of patients rehospitalized was 411 (3.94%) within 90 days after discharge, 1278 (12.26%) within 180 days, 2,492 (23.90%) within a year, 3,712 (35.60%) within two years, and 4,473 (42.90%) within three years. Rehospitalization rate is similar to previous study, 33 although it was higher than that of incipient schizophrenia. 15 We found that among the comorbidities, presence of depression increased the number of outpatient visits within 60 days after discharge. However, all the comorbidities including depression increased the risk of rehospitalization as well. Taken together, depression can increase outpatient visit and rehospitalization at the same time which is inherently inconsistent with our main result. Positive and negative symptoms of schizophrenia have been shown to be associated with depression and anxiety which may lower the satisfaction of treatment and quality of life in patients with schizophrenia. [43] [44] [45] [46] Especially, depression in the first hospitalization reduces drug compliance and increases early recurrence and hospitalization. 21, 33, 47 Therefore, it is conceivable that the increased outpatient visit in patients with depression should not be interpreted as a good compliance to maintenance treatment. Rather depression per se and/or negative symptoms of schizophrenia increases the necessity of outpatient treatment and the risk of rehospitalization. In this study, depression was present in 14.7% (n=27) of patients with schizophrenia, which is lower than the prevalence of depression in general population (25%). 48, 49 Lower prevalence might be resulted from the inexactness of secondary diagnosis in NHICD, and partially from difficulty to differentiate depression from negative symptoms of schizophrenia. Hence, diagnosis of comorbid depression in schizophrenia is challenging but worthy of clinical attention to evaluate the risk of rehospitalization.
Age and sex were found to have a statistically significant association with the increased outpatient visits. Males showed fewer visits than females, which is consistent with the previous study result showing a lower treatment maintenance rate in men. 50 On the other hand, it is also reported that there was no significant difference between sexes. 20, 51 As to the rehospialization risk, we found that female sex and older age are protective factors against rehospitalization. This result is consis- Number of outpatient visit tent with previous studies. 29, 52 Green et al. reported that rehospitalization is more frequent in the patients under the age of 40 years. 29 There are controversy about the effect of sex on rehospitalization rate. 28, 34 Pharmacotherapy is one of the critical factor in the treatment of schizophrenia. In this study, the group taking atypical antipsychotics showed more outpatient visits and a lower risk of rehospitalization than the group taking typical antipsychotics. It is known that the group taking atypical antipsychotics has a lower treatment discontinuation rate, 16, 53 higher drug compliance, [53] [54] [55] [56] and lower rehospitalization rate. 53 Higher medication adherence with taking atypical antipsychotics might be due to less side effects like extrapyramidal symptoms and tardive dyskinesia. [57] [58] [59] [60] [61] [62] However, some reports did not show the difference in drug compliance between typical and atypical antipsychotics. 63, 64 Olfson et al. 63 proposed that the risk factors lowering drug compliance of discharged patients with schizophrenia, including past history of drug non-compliance, recent drug use, status that patients could not recognize their symptoms, weak relationship with staffs during the hospitalization, and the refusal of family members to intervene the patients' hospitalization. Eventually patients with low drug compliance could be easily dropped out although they had some outpatient visits.
We also found the number of outpatient visits is different according to the type and location of medical institutions. Primary clinic and metropolitan city showed relatively higher outpatient visit rate. It has been reported that outpatient treatment rate was higher in smaller hospitals and in the area with a higher ratio of psychiatrists per capita. 65 Our results are consistent with previous report in that metropolitan city should have better accessibility to psychiatrists due to the higher ratio of psychiatrists per capita than rural area. From the perspective of the type of medical institutions, hospitals and primary clinics were consistently found to have higher rehospitalization risk than general hospitals. Considering the general tendencies that patients in acute phase or with good supporting system in a higher social and economic class tend to be hospitalized in general hospitals, the difference in rehospitalization rate may be resulted from the difference in patient group rather than treatment quality.
We also analyzed past hospitalization history and LOS as potential factors affecting outpatient visits and rehospitlization. We report that past hospitalization history increased the risk of rehospitalization, as similar findings have been reported. 10, 33, 34, 66 Although our data showed association between a longer LOS and more outpatient visits, it does not change the rehospitalization risk. In contrast, some previous studies reported that shorter LOS was related with vulnerability to recurrence, 10, 28 although there are some equivocal results as well. 11, 24, 65 Korea has a single government-operated health insurance system. In particular, an enormous amount of NHI-CD has been accumulated as 99.9% of claims have been made via computerized network since 2007. 67 NHICD the source of data for our study has strength in terms of representativeness, objectiveness and cost effectiveness. On the other hand, there is a possibility that the validity of diagnoses might be undermined by simple coding inaccuracy. However, in spite of general weak point of NHICD, the diagnosis of schizophrenia in our study should be more accurate than those of other diseases for several reasons. First, National Health Insurance Corporation requests careful diagnosis of the diseases under the application of "special benefit computation", including schizophrenia, Second, the diagnosis of schizophrenia is regarded as more serious because of the worries of potential social stigma. Third, we limited the subjects to those hospitalized in psychiatric institutions.
In the past, there were studies regarding outpatient visits after discharge in Korea but they were based on clinical studies. Therefore, the patients were not representative of the whole population and the number of subjects was smaller, because they were performed in a single medical institution. 51 There have been some researches using national data, such as National Hospital Discharge Register in Finland from which mortality of schizophrenia was traced and correlation of antidepressant with suicidal risk and suicidal attempts was studied. 68, 69 As such, NHICD included data of all the patients diagnosed as a certain disease in all medical institutions. Therefore, generalizability and representativeness are the biggest strength of this study in that the cases visiting multiple institutions after discharge could be counted in outpatient visit compliance based on NHICD.
Limitations 1) Diagnosis in NHICD can be less accurate than the diagnosis through face-to-face structured interview. 2) Clinical information such as duration of untreated psychosis, intensity of symptoms and drug prescription during the hospitalization, and the use of community psychiatric service could not be considered in our study. Medical record review might enable in-depth analysis in the future. As this is a retrospective cohort study using NHICD, there are limitations in the method of study and characteristics of materials. Further study to overcome those limitation is warranted.
In this study, outpatient treatment within 60 days after discharge for patients with schizophrenia is an important indicator of rehospitalization within a year. We suggest that rehospitalization rate may be reduced if outpatient visits are maintained after discharge, especially within 60 days. Development of systematic and effective management program to increase outpatient treatment rate and drug compliance should have very important clinical implication.
